drugset / Trial / NCT06483373

A Clinical Study of SPH7854 Granules in Healthy Subjects.

NCT06483373 ↗

Phase 0 Recruiting 111 enrolled Shanghai Pharmaceuticals Holding Co., Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the safety of SPH7854 in healthy subjects.

Timeline

Start
2024-05-28
Primary completion
2026-12-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject SPH7854 Unknown 50 mg Oral
Subject SPH7854 Unknown 3200 mg Oral